No Data
PainReform Ltd. Gains $3.17 Million From Warrant Exercise
PainReform Shares Are Trading Lower. The Company Announced an Update Regarding Its Phase 3 Clinical Trial Evaluating PRF-110 in Post-surgical Pain Management of Patients Undergoing Bunionectomy.
Express News | PainReform Shares Down 24.9% Premarket After Pain Relief Treatment Fails to Meet Main Goal in Late Stage Trial
PainReform Down 38% After Resuming Trading
PainReform Phase 3 Trial on PRF-110 Did Not Meet Primary Endpoint
Express News | PainReform Ltd: Data From Final 24-Hour Period Could Not Be Clarified to Satisfy Study's Primary Endpoint 72 Hours Requirement
No Data
now
may be still buy candidate I asked advanced A.I swing analyst last night & said to me “it’s still buy if test $12.00 magnetic psychological 
level and became support for upside bullish rally till 29/30$ easy with high risky bet trade scared 
“